Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Beaulieu Joseph, Autre. Insider active across 1 company, notably Epizyme, Inc.. Aggregated, 6 disclosures have been published. Split: 0 buy · 2 sells. Total volume traded: €1k. History available since 16 August 2021. The latest transaction was filed on 9 August 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Joseph Beaulieu is the Corporate Controller at Epizyme, Inc. His role is specified by remarks, highlighting his commitment to the company. His expertise and contributions are important for the development and strategy of Epizyme.